English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17481/19828 (88%)
Visitors : 6353535      Online Users : 58
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/32669


    標題: Xanthohumol Suppresses NPC1L1 Gene Expression through Downregulation of HNF-4 alpha( )and Inhibits Cholesterol Uptake in Caco-2 Cells
    作者: Thang, Sang Kim
    Chen, Pei-Yi
    Gao, Wan-Yun
    Wu, Ming-Jiuan
    Pan, Min-Hsiung
    Yen, Jui-Hung
    貢獻者: Tzu Chi Univ, Inst Med Sci
    Hualien Tzu Chi Hosp, Buddhist Tzu Chi Fdn, Ctr Med Genet
    Tzu Chi Univ, Dept Mol Biol & Human Genet
    Chia Nan Univ Pharm & Sci, Dept Biotechnol
    Natl Taiwan Univ, Inst Food Sci & Technol
    關鍵字: xanthohumol
    cholesterol absorption
    NPC1L1
    HNF-4 alpha
    statin
    日期: 2019
    上傳時間: 2020-07-29 13:54:32 (UTC+8)
    出版者: AMER CHEMICAL SOC
    摘要: Xanthohumol (Xan) is a prenylated chalcone mainly found in hops; it has been demonstrated to function against hypercholesterolemia, hyperlipidemia, and atherosclerosis. In this study, we focused on the hypocholesterolemic effect of Xan on cholesterol uptake and the underlying molecular mechanisms of Xan in human intestinal Caco-2 cells. The microarray data showed that Niemann-Pick C1-like 1 (NPC1L1), an essential transporter for dietary cholesterol absorption, was significantly downregulated in Xan-treated Caco-2 cells. We demonstrated that Xan (10 and 20 mu M) suppressed the mRNA and protein expression of NPC1L1 by 0.65 +/- 0.12-fold and 0.54 +/- 0.15-fold and 0.72 +/- 0.04-fold and 0.44 +/- 0.12-fold, respectively, compared to that of the vehicle-treated Caco-2 cells. Moreover, Xan (10 and 20 mu M) significantly inhibited cholesterol uptake by approximately 12 and 32% in Caco-2 cells. NPC1L1 promoter activity was significantly suppressed by Xan, and a DNA element within the NPC1L1 promoter involved in Xan-mediated NPC1L1 reduction located between the -120 and -20 positions was identified. Moreover, Xan markedly decreased the mRNA and protein levels of hepatocyte nuclear factor 4 alpha (HNF-4 alpha), a critical activator of NPC1L1 transcription, and subsequently attenuated HNF-4 alpha/NPC1L1 promoter complex formation, resulting in the suppression of NPC1L1 gene expression. Finally, we demonstrated that Xan markedly abolished lovastatin-induced NPC1L1 overexpression in Caco-2 cells. These findings reveal that Xan suppresses NPC1L1 expression via downregulation of HNF-4 alpha and exerts inhibitory effects on cholesterol uptake in the intestinal Caco-2 cells. Our findings suggest Xan could serve as a potential cholesterol-lowering agent and supplement for statin therapy.
    關聯: Journal of Agricultural and Food Chemistry, v.67, n.40, pp.
    Appears in Collections:[生物科技系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML21View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback